Titre : Maladie des légionnaires

Maladie des légionnaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Network Meta-Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Maladie des légionnaires : Questions médicales les plus fréquentes", "headline": "Maladie des légionnaires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Maladie des légionnaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-22", "dateModified": "2025-04-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Maladie des légionnaires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Légionellose", "url": "https://questionsmedicales.fr/mesh/D007876", "about": { "@type": "MedicalCondition", "name": "Légionellose", "code": { "@type": "MedicalCode", "code": "D007876", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.730.382" } } }, "about": { "@type": "MedicalCondition", "name": "Maladie des légionnaires", "alternateName": "Legionnaires' Disease", "code": { "@type": "MedicalCode", "code": "D007877", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sophie Jarraud", "url": "https://questionsmedicales.fr/author/Sophie%20Jarraud", "affiliation": { "@type": "Organization", "name": "Institut des Agents Infectieux, Centre National de Référence des Légionelles, Hospices Civils de Lyon, Lyon, France. sophie.jarraud@univ-lyon1.fr." } }, { "@type": "Person", "name": "Chris Edens", "url": "https://questionsmedicales.fr/author/Chris%20Edens", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Christophe Ginevra", "url": "https://questionsmedicales.fr/author/Christophe%20Ginevra", "affiliation": { "@type": "Organization", "name": "The National Reference Center of Legionella, 69317 Lyon, France." } }, { "@type": "Person", "name": "Lara Payne Hallström", "url": "https://questionsmedicales.fr/author/Lara%20Payne%20Hallstr%C3%B6m", "affiliation": { "@type": "Organization", "name": "European Centre for Disease Prevention and Control (ECDC), Solna, Sweden." } }, { "@type": "Person", "name": "Kelsie Cassell", "url": "https://questionsmedicales.fr/author/Kelsie%20Cassell", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology of Microbial Diseases, School of Public Health, Yale University, New Haven, Connecticut." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Tocolytics for delaying preterm birth: a network meta-analysis (0924).", "datePublished": "2022-08-10", "url": "https://questionsmedicales.fr/article/35947046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD014978.pub2" } }, { "@type": "ScholarlyArticle", "name": "Bayesian unanchored additive models for component network meta-analysis.", "datePublished": "2022-07-17", "url": "https://questionsmedicales.fr/article/35844085", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/sim.9520" } }, { "@type": "ScholarlyArticle", "name": "Pharmacological treatments in panic disorder in adults: a network meta-analysis.", "datePublished": "2023-11-28", "url": "https://questionsmedicales.fr/article/38014714", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD012729.pub3" } }, { "@type": "ScholarlyArticle", "name": "Thresholds for surfactant use in preterm neonates: a network meta-analysis.", "datePublished": "2022-12-09", "url": "https://questionsmedicales.fr/article/36600484", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/archdischild-2022-324184" } }, { "@type": "ScholarlyArticle", "name": "Cardiotoxicity of immune checkpoint inhibitors: A frequency network meta-analysis.", "datePublished": "2022-09-14", "url": "https://questionsmedicales.fr/article/36189211", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.1006860" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Infections de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012141" }, { "@type": "ListItem", "position": 4, "name": "Légionellose", "item": "https://questionsmedicales.fr/mesh/D007876" }, { "@type": "ListItem", "position": 5, "name": "Maladie des légionnaires", "item": "https://questionsmedicales.fr/mesh/D007877" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Maladie des légionnaires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Maladie des légionnaires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Maladie des légionnaires", "description": "Comment diagnostique-t-on la maladie des légionnaires ?\nQuels tests sont utilisés pour confirmer l'infection ?\nLes radiographies sont-elles utiles pour le diagnostic ?\nQuels symptômes orientent vers un diagnostic de légionellose ?\nLa biopsie pulmonaire est-elle nécessaire pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Maladie des légionnaires", "description": "Quels sont les symptômes courants de la maladie des légionnaires ?\nLa diarrhée est-elle un symptôme possible ?\nLes symptômes apparaissent-ils rapidement ?\nY a-t-il des symptômes spécifiques chez les personnes âgées ?\nLa confusion mentale est-elle un symptôme associé ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Maladie des légionnaires", "description": "Comment prévenir la maladie des légionnaires ?\nLes systèmes de climatisation doivent-ils être surveillés ?\nLes personnes à risque doivent-elles prendre des précautions ?\nLes douches peuvent-elles être une source de contamination ?\nDes vaccins existent-ils pour prévenir cette maladie ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Maladie des légionnaires", "description": "Quel est le traitement principal de la maladie des légionnaires ?\nLes corticostéroïdes sont-ils recommandés ?\nQuelle est la durée du traitement antibiotique ?\nDes soins de soutien sont-ils nécessaires ?\nLes patients doivent-ils être hospitalisés ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Maladie des légionnaires", "description": "Quelles sont les complications possibles de la légionellose ?\nLa maladie peut-elle entraîner des séquelles ?\nLes personnes âgées sont-elles plus à risque de complications ?\nComment les complications sont-elles gérées ?\nLe décès est-il possible en cas de légionellose ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Maladie des légionnaires", "description": "Quels sont les principaux facteurs de risque ?\nLes fumeurs sont-ils plus susceptibles de contracter la maladie ?\nLes personnes immunodéprimées sont-elles à risque ?\nLes voyages peuvent-ils augmenter le risque d'infection ?\nLes antécédents de pneumonie augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la maladie des légionnaires ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests de culture des expectorations ou des analyses sanguines." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer l'infection ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests PCR et les tests d'antigènes urinaires sont couramment utilisés." } }, { "@type": "Question", "name": "Les radiographies sont-elles utiles pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les radiographies thoraciques montrent souvent des infiltrats pulmonaires." } }, { "@type": "Question", "name": "Quels symptômes orientent vers un diagnostic de légionellose ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, toux, dyspnée et douleurs thoraciques sont des indicateurs clés." } }, { "@type": "Question", "name": "La biopsie pulmonaire est-elle nécessaire pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Rarement, elle est utilisée si les autres tests ne sont pas concluants." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la maladie des légionnaires ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, toux, essoufflement, douleurs musculaires et maux de tête sont fréquents." } }, { "@type": "Question", "name": "La diarrhée est-elle un symptôme possible ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la diarrhée peut survenir chez certains patients atteints de légionellose." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître 2 à 10 jours après l'exposition à la bactérie." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les personnes âgées ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent présenter des symptômes plus graves et des complications." } }, { "@type": "Question", "name": "La confusion mentale est-elle un symptôme associé ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la confusion ou des troubles neurologiques peuvent se manifester dans les cas graves." } }, { "@type": "Question", "name": "Comment prévenir la maladie des légionnaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir les systèmes d'eau propres et contrôler la température de l'eau est essentiel." } }, { "@type": "Question", "name": "Les systèmes de climatisation doivent-ils être surveillés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les systèmes de climatisation doivent être régulièrement entretenus pour éviter la contamination." } }, { "@type": "Question", "name": "Les personnes à risque doivent-elles prendre des précautions ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées et immunodéprimées doivent éviter les environnements à risque." } }, { "@type": "Question", "name": "Les douches peuvent-elles être une source de contamination ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les douches peuvent libérer des aérosols contenant la bactérie Legionella." } }, { "@type": "Question", "name": "Des vaccins existent-ils pour prévenir cette maladie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccin efficace contre la maladie des légionnaires." } }, { "@type": "Question", "name": "Quel est le traitement principal de la maladie des légionnaires ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques, comme la lévofloxacine ou l'azithromycine, sont utilisés." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils recommandés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils ne sont généralement pas recommandés, sauf en cas de complications sévères." } }, { "@type": "Question", "name": "Quelle est la durée du traitement antibiotique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dure généralement 10 à 14 jours, selon la gravité de l'infection." } }, { "@type": "Question", "name": "Des soins de soutien sont-ils nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'oxygénothérapie et l'hydratation peuvent être nécessaires pour les patients graves." } }, { "@type": "Question", "name": "Les patients doivent-ils être hospitalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la gravité des symptômes; les cas sévères nécessitent souvent une hospitalisation." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la légionellose ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance respiratoire, le choc septique et la défaillance multiviscérale." } }, { "@type": "Question", "name": "La maladie peut-elle entraîner des séquelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent avoir des séquelles pulmonaires à long terme." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque de complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru de complications graves et de mortalité." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications nécessitent souvent des soins intensifs et un traitement symptomatique." } }, { "@type": "Question", "name": "Le décès est-il possible en cas de légionellose ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la légionellose peut être mortelle, surtout chez les personnes à risque." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge avancé, le tabagisme, et les maladies chroniques." } }, { "@type": "Question", "name": "Les fumeurs sont-ils plus susceptibles de contracter la maladie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de développer une légionellose." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées ont un risque accru d'infection sévère." } }, { "@type": "Question", "name": "Les voyages peuvent-ils augmenter le risque d'infection ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages dans des zones avec des systèmes d'eau contaminés augmentent le risque." } }, { "@type": "Question", "name": "Les antécédents de pneumonie augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir des antécédents de pneumonie peut prédisposer à la légionellose." } } ] } ] }

Sources (10000 au total)

Tocolytics for delaying preterm birth: a network meta-analysis (0924).

Preterm birth is the leading cause of death in newborns and children. Tocolytic drugs aim to delay preterm birth by suppressing uterine contractions to allow time for administration of corticosteroids... To estimate relative effectiveness and safety profiles for different classes of tocolytic drugs for delaying preterm birth, and provide rankings of the available drugs.... We searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov (21 April 2021) and reference lists of retrieved studies.... We included all randomised controlled trials assessing effectiveness or adverse effects of tocolytic drugs for delaying preterm birth. We excluded quasi- and non-randomised trials. We evaluated all st... At least two review authors independently assessed the trials for inclusion and risk of bias, and extracted data. We performed pairwise and network meta-analyses, to determine the relative effects and... This network meta-analysis includes 122 trials (13,697 women) involving six tocolytic classes, combinations of tocolytics, and placebo or no treatment. Most trials included women with threatened prete... Compared with placebo or no tocolytic treatment, all tocolytic drug classes that we assessed (betamimetics, calcium channel blockers, magnesium sulphate, oxytocin receptor antagonists, nitric oxide do...

Pharmacological treatments in panic disorder in adults: a network meta-analysis.

A panic attack is a discrete period of fear or anxiety that has a rapid onset and reaches a peak within 10 minutes. The main symptoms involve bodily systems, such as racing heart, chest pain, sweating... To compare, via network meta-analysis, individual drugs (antidepressants and benzodiazepines) or placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or withou... We searched the Cochrane Common Mental Disorders Specialised Register, CENTRAL, CDSR, MEDLINE, Ovid Embase and PsycINFO to 26 May 2022.... We included randomised controlled trials (RCTs) of people aged 18 years or older of either sex and any ethnicity with clinically diagnosed panic disorder, with or without agoraphobia. We included tria... Two authors independently screened titles/abstracts and full texts, extracted data and assessed risk of bias. We analysed dichotomous data and continuous data as risk ratios (RRs), mean differences (M... Overall, we included 70 trials in this review. Sample sizes ranged between 5 and 445 participants in each arm, and the total sample size per study ranged from 10 to 1168. Thirty-five studies included ... In terms of efficacy, SSRIs, SNRIs (venlafaxine), TCAs, MAOIs and BDZs may be effective, with little difference between classes. However, it is important to note that the reliability of these findings...

Thresholds for surfactant use in preterm neonates: a network meta-analysis.

To perform a network meta-analysis of randomised controlled trials of different surfactant treatment strategies for respiratory distress syndrome (RDS) to assess if a certain fraction of inspired oxyg... Systematic review and network meta-analysis using Bayesian analysis of randomised trials of prophylactic versus selective surfactant for RDS.... Cochrane Central Register of Controlled Trials, MEDLINE, Embase and Science Citation Index Expanded.... Randomised trials including infants under 32 weeks of gestational age.... Intratracheal surfactant, irrespective of type or dose.... Our primary outcome was neonatal mortality, compared between groups treated with selective surfactant therapy at different thresholds of FiO... Of 4643 identified references, 14 studies involving 5298 participants were included. We found no statistically significant differences between 30%, 40% and 50% FiO... Our results do not show a clear benefit of surfactant treatment at any threshold of FiO... CRD42020166620....

Common bile duct stones management: A network meta-analysis.

Timely management is critical for treating symptomatic common bile duct (CBD) stones; however, a single optimal management strategy has yet to be defined in the acute care setting. Consequently, this ... PubMed, SCOPUS, MEDLINE, Embase, and Cochrane Central Register of Controlled Trials were methodically queried for articles from 2010 to 2021. The search terms were a combination of medical subject hea... A total of 16 studies (8,644 participants) addressing the LOS and 41 studies (19,756 participants) addressing postprocedural complications were included in the analysis. The one-stage approaches were ... This network meta-analysis suggests that both laparoscopic CBD exploration and intraoperative ERCP have equally good outcomes and provide a preferable single-anesthesia patient pathway with a shorter ... Systematic Review/Meta Analysis; Level III....

Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis.

In recent years a broader range of immunomodulatory and immunosuppressive treatment options have emerged for people with progressive forms of multiple sclerosis (PMS). While consensus supports these o... To compare through network meta-analysis the efficacy and safety of alemtuzumab, azathioprine, cladribine, cyclophosphamide, daclizumab, dimethylfumarate, diroximel fumarate, fingolimod, fludarabine, ... We searched CENTRAL, MEDLINE, and Embase up to August 2022, as well as ClinicalTrials.gov and the WHO ICTRP.... Randomised controlled trials (RCTs) that studied one or more treatments as monotherapy, compared to placebo or to another active agent, for use in adults with PMS.... Two review authors independently selected studies and extracted data. We performed data synthesis by pair-wise and network meta-analysis. We assessed the certainty of the body of evidence according to... We included 23 studies involving a total of 10,167 participants. The most frequent (39% of studies) reason for a rating of high risk of bias was sponsor role in study authorship and data management an... The number of people with PMS with relapses is probably slightly reduced with rituximab at two years, and interferon beta-1b at three years, compared to placebo. Both drugs are also probably associate...

Moist dressings in the treatment of pressure injuries: A network meta-analysis.

The aim of this network meta-analysis is to analyze the difference in therapeutic effects between moist dressings and traditional dressings in the treatment of pressure injury (PI), explore the healin... The incidence of pressure injury is high and the burden of disease is high, but there is no consensus on how to choose moist dressing treatment.... A systematic review with network meta-analysis was performed.... We searched the Chinese Biomedicine Literature Database and China National Knowledge Infrastructure, Wanfang Database, VIP database, PubMed, Web of Science, EMBASE.com, CENTRAL (Cochrane Central Regis... R studio software and Stata 16.0 software were used to compare different moist dressings and traditional dressings.... 41 RCTs of moist dressings in the treatment of PI were included. A total of seven kinds of moist dressings, Vaseline gauze and traditional gauze dressing were involved. All RCTs were at a medium to hi... The effect of moist dressings in treating PI is more advantageous than traditional dressings. However, in terms of direct cost and the number of dressings changes, more research is needed to improve t... This study is a network meta-analysis, which does not require the participation of patients and the public....